Leadless Pacemakers Market Overview

The report is titled ‘Leadless Pacemakers Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the leadless pacemakers market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Leadless pacemakers market is expected to grow at a significant rate in the near future.

The global leadless pacemakers market in 2020 is estimated for more than US$ 31.3 Mn and expected to reach a value of US$ 69.9 Mn by 2028 with a significant CAGR of 10.6%.

Leadless Pacemakers Market Definition

A medical device that assists a person’s heartbeat more regularly is known as the pacemaker.  The artificial cardiac pacemaker is a tiny medical device placed in the chest of the patient through a surgical procedure in order to regulate the heartbeat of the person if it is slower or irregular than usual.

Basically, the artificial cardiac pacemaker provokes electrical impulses conveyed by electrodes in order to contract the heart muscle chambers and thereby pump blood. The pacemaker regulates and/or replaces the function of the electrical conduction system of the heart.

Further, leadless pacemakers have been recently introduced to the global market with some of the most essential benefits as well as few drawbacks. Primarily, the leadless pacemaker is much tinier than the usual transvenous pacemaker and more importantly, it can be put into the patient’s chest without any surgery as it is implanted through a femoral vein transcatheter approach. Owing to such benefits, the leadless pacemakers are projected to witness huge demand in the global market in the forthcoming years.

Leadless Pacemakers Market Dynamics

The constantly increasing count of patients suffering from cardiovascular ailments and other heart-related problems, particularly arrhythmias, across the world is one of the major drivers projected to give a positive push to the growth of the global leadless pacemaker market in the near future.

By the same token, a huge upsurge in the geriatric population all across the world, as well as the sluggish lifestyle of the population with desk-bound jobs and unhealthy diets, is also contributing to the growing count of heart patients worldwide, thereby elevating the demand for leadless pacemakers in the near future. Therefore, the global leadless pacemaker market is projected to observe rapid growth during the forecast period.

Along with that, the leadless pacemaker is way smaller than the usual pacemaker and it requires no chest incision for the implantation, which further stimulates its demand over usual transvenous pacemakers. Attributing to such factors, the global leadless pacemaker market is expected to observe a breakthrough in the near future.

Furthermore, the leadless pacemaker is a self-sufficient generator and electrode system embedded directly into the right ventricle along with the absence of leads thus eradicating potential lead and pacemaker pocket related complications, hence the global leadless pacemaker market is expected to flourish swiftly in the coming years.

However, there are also some restraining factors such as stringent regulatory approvals, the huge cost of the product, and lack of experienced operators, and battery exhaustion issues, which may refrain the growth of the global leadless pacemaker market during the forecast timeframe.

Leadless Pacemakers Market Segmentation

The Leadless Pacemakers market is segmented on the basis of indication, technology, end-user, and by region.

On the basis of indication, the leadless pacemakers market is segmented into

•    Atrial Fibrillation

•    High Degree Atrioventricular Block

•    Sinus node dysfunction

On the basis of technology, the market is segmented into

•    Micra Transcatheter Pacing System

•    Nanostim Leadless Pacemakers

•    Wireless Cardiac Simulation System

On the basis of End User, the market is segmented into

•    Hospitals

•    Catheterization Laboratories

On the basis of Region, the leadless pacemakers market is segmented into

•    North America (U.S., Canada)

•    Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

•    Europe (U.K., Germany, Italy, France, Spain, Russia, Poland, BENELUX, NORDIC)

•    Asia Pacific (China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia)

•    Middle East (GCC Countries, Israel, Oman, Rest of Middle East)

•    Africa (South Africa, Egypt, North Africa, Rest of Africa)

Leadless Pacemakers Market Key Players

Some of the key participating players in the leadless pacemakers market are Medtronic, St. Jude Medical LLC, Biotronic, Boston Scientific, Edwards Lifesciences, Sorin Group, Vitatron, Lepu Medical, and Terumo Corp.

MMC Overview on Leadless Pacemakers Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Leadless Pacemakers market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Leadless Pacemakers

•    Advantages of Leadless Pacemakers

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make an informed decision.

A mix of top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.

1.    Global Leadless Pacemakers Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Leadless Pacemakers Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Leadless Pacemakers Market Snapshot

2.4.    Global Leadless Pacemakers Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Leadless Pacemakers Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Leadless Pacemakers Market, By Indication

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Indication

3.1.2.    BPS Analysis, By Indication

3.2.    Market Revenue (US$Mn) Forecast, By Indication

3.2.1.    Atrial Fibrillation

3.2.2.    High Degree Atrioventricular Block

3.2.3.    Sinus node dysfunction

3.3.    Global Leadless Pacemakers Market Attractiveness Index, By Indication

4.    Global Leadless Pacemakers Market, By Technology

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Technology

4.1.2.    BPS Analysis, By Technology

4.2.    Market Revenue (US$Mn) Forecast, By Technology

4.2.1.    Micra Transcatheter Pacing System

4.2.2.    Nanostim Leadless Pacemakers

4.2.3.    Wireless Cardiac Simulation System

4.3.    Global Leadless Pacemakers Market Attractiveness Index, By Technology

5.    Global Leadless Pacemakers Market, By End User

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By End User

5.1.2.    BPS Analysis, By End User

5.2.    Market Revenue (US$Mn) Forecast, By End User

5.2.1.    Hospitals

5.2.2.    Catheterization Laboratories

5.3.    Global Leadless Pacemakers Market Attractiveness Index, By End User

6.    Global Leadless Pacemakers Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Leadless Pacemakers Market Attractiveness Index, By Region

7.    North America Leadless Pacemakers Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Leadless Pacemakers Market

7.2.2.    Canada Leadless Pacemakers Market

7.3.    North America Leadless Pacemakers Market, By Indication

7.3.1.    Atrial Fibrillation

7.3.2.    High Degree Atrioventricular Block

7.3.3.    Sinus node dysfunction

7.4.    North America Leadless Pacemakers Market, By Technology

7.4.1.    Micra Transcatheter Pacing System

7.4.2.    Nanostim Leadless Pacemakers

7.4.3.    Wireless Cardiac Simulation System

7.5.    North America Leadless Pacemakers Market, By End User

7.5.1.    Hospitals

7.5.2.    Catheterization Laboratories

7.6.    North America Leadless Pacemakers Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Indication

7.6.3.    By Technology

7.6.4.    By End User

8.    Latin America Leadless Pacemakers Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Leadless Pacemakers Market

8.2.2.    Mexico Leadless Pacemakers Market

8.2.3.    Argentina Leadless Pacemakers Market

8.2.4.    Rest of Latin America Leadless Pacemakers Market

8.3.    Latin America Leadless Pacemakers Market, By Indication

8.3.1.    Atrial Fibrillation

8.3.2.    High Degree Atrioventricular Block

8.3.3.    Sinus node dysfunction

8.4.    Latin America Leadless Pacemakers Market, By Technology

8.4.1.    Micra Transcatheter Pacing System

8.4.2.    Nanostim Leadless Pacemakers

8.4.3.    Wireless Cardiac Simulation System

8.5.    Latin America Leadless Pacemakers Market, By End User

8.5.1.    Hospitals

8.5.2.    Catheterization Laboratories

8.6.    Latin America Leadless Pacemakers Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Indication

8.6.3.    By Technology

8.6.4.    By End User

9.    Europe Leadless Pacemakers Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Leadless Pacemakers Market

9.2.2.    Germany Leadless Pacemakers Market

9.2.3.    Italy Leadless Pacemakers Market

9.2.4.    France Leadless Pacemakers Market

9.2.5.    Spain Leadless Pacemakers Market

9.2.6.    Russia Leadless Pacemakers Market

9.2.7.    Poland Leadless Pacemakers Market

9.2.8.    BENELUX Leadless Pacemakers Market

9.2.9.    NORDIC Leadless Pacemakers Market

9.2.10.    Rest of Europe Leadless Pacemakers Market

9.3.    Europe Leadless Pacemakers Market, By Indication

9.3.1.    Atrial Fibrillation

9.3.2.    High Degree Atrioventricular Block

9.3.3.    Sinus node dysfunction

9.4.    Europe Leadless Pacemakers Market, By Technology

9.4.1.    Micra Transcatheter Pacing System

9.4.2.    Nanostim Leadless Pacemakers

9.4.3.    Wireless Cardiac Simulation System

9.5.    Europe Leadless Pacemakers Market, By End User

9.5.1.    Hospitals

9.5.2.    Catheterization Laboratories

9.6.    Europe Leadless Pacemakers Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Indication

9.6.3.    By Technology

9.6.4.    By End User

10.    Asia Pacific Leadless Pacemakers Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Leadless Pacemakers Market

10.2.2.    India Leadless Pacemakers Market

10.2.3.    Japan Leadless Pacemakers Market

10.2.4.    Australia and New Zealand Leadless Pacemakers Market

10.2.5.    South Korea Leadless Pacemakers Market

10.2.6.    ASEAN Leadless Pacemakers Market

10.2.7.    Rest of Asia Pacific Leadless Pacemakers Market

10.3.    Asia Pacific Leadless Pacemakers Market, By Indication

10.3.1.    Atrial Fibrillation

10.3.2.    High Degree Atrioventricular Block

10.3.3.    Sinus node dysfunction

10.4.    Asia Pacific Leadless Pacemakers Market, By Technology

10.4.1.    Micra Transcatheter Pacing System

10.4.2.    Nanostim Leadless Pacemakers

10.4.3.    Wireless Cardiac Simulation System

10.5.    Asia Pacific Leadless Pacemakers Market, By End User

10.5.1.    Hospitals

10.5.2.    Catheterization Laboratories

10.6.    Asia Pacific Leadless Pacemakers Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Indication

10.6.3.    By Technology

10.6.4.    By End User

11.    Middle East Leadless Pacemakers Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Leadless Pacemakers Market

11.2.2.    Israel Leadless Pacemakers Market

11.2.3.    Oman Leadless Pacemakers Market

11.2.4.    Rest of Middle East Leadless Pacemakers Market

11.3.    Middle East Leadless Pacemakers Market, By Indication

11.3.1.    Atrial Fibrillation

11.3.2.    High Degree Atrioventricular Block

11.3.3.    Sinus node dysfunction

11.4.    Middle East Leadless Pacemakers Market, By Technology

11.4.1.    Micra Transcatheter Pacing System

11.4.2.    Nanostim Leadless Pacemakers

11.4.3.    Wireless Cardiac Simulation System

11.5.    Middle East Leadless Pacemakers Market, By End User

11.5.1.    Hospitals

11.5.2.    Catheterization Laboratories

11.6.    Middle East Leadless Pacemakers Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Indication

11.6.3.    By Technology

11.6.4.    By End User

12.    Africa Leadless Pacemakers Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Leadless Pacemakers Market

12.2.2.    Egypt Leadless Pacemakers Market

12.2.3.    North Africa Leadless Pacemakers Market

12.2.4.    Rest of Africa Leadless Pacemakers Market

12.3.    Africa Leadless Pacemakers Market, By Indication

12.3.1.    Atrial Fibrillation

12.3.2.    High Degree Atrioventricular Block

12.3.3.    Sinus node dysfunction

12.4.    Africa Leadless Pacemakers Market, By Technology

12.4.1.    Micra Transcatheter Pacing System

12.4.2.    Nanostim Leadless Pacemakers

12.4.3.    Wireless Cardiac Simulation System

12.5.    Africa Leadless Pacemakers Market, By End User

12.5.1.    Hospitals

12.5.2.    Catheterization Laboratories

12.6.    Africa Leadless Pacemakers Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Indication

12.6.3.    By Technology

12.6.4.    By End User

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Medtronic

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Product Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    St. Jude Medical LLC

14.3.3.    Biotronic

14.3.4.    Boston Scientific

14.3.5.    Edwards Lifesciences

14.3.6.    Sorin Group

14.3.7.    Vitatron

14.3.8.    Lepu Medical

14.3.9.    Terumo Corp.

14.3.10.    Others

15.    Acronyms